Using a proprietary technology platform in development of immunotherapy treatments to fight cancer Company recently announced proposed investment by leading biotech funds and concurrent non-brokered financing for combined gross proceeds of up to $4.8 million Using social media to raise awareness and expand patient recruitment for Bria-IMT™ clinical trials BriaCell Therapeutics Corp. (TSX.V: BCT) (OTCQB: […]
The Stocks To Buy Now Blog
Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.